Immunotherapy in Combination with Chemotherapy for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks estrogen and progesterone receptors and does not overexpress the human epidermal growth factor receptor 2 (HER2). Previous treatment options for TNBC were limited to chemotherapy alone, resulting in a poor pati...

Full description

Saved in:
Bibliographic Details
Other Authors: Meléndez-Solano, Elizabeth, Chapa, Christian, Stevens Barrón, Jazmín Cristina
Format: Artículo
Published: 2023
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items